Tilray Analysts On The Sidelines Despite Solid Earnings

Canadian cannabis companies Tilray Inc. (NASDAQ:TLRY) and Aphria Inc. (NASDAQ:APHA) have agreed to a merger. Meanwhile, Tilray announced strong fourth-quarter results, with meaningful revenue growth and margin expansion. The Tilray Analysts:. Michael Lavery of Piper Sandler downgraded the rating from Overweight to Neutral, while raising the price target from $15...